No definition available.
Other infections specific to the perinatal period
P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
209 |
Control definitions (FinnGen only)
- Control exclude
- P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P3
- Name in latin
- Alii infectiones temporis perinatalis specificae
Similar endpoints
↥List of similar endpoints to
Other infections specific to the perinatal period
based on the number of shared cases.
Similar with more cases:
- Infections specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15148 | 6214 | 8934 |
| Only index persons | 9358 | 3723 | 5635 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.22 | 0.18 | 0.25 |
| Only index persons | 0.18 | 0.14 | 0.22 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 109 | 100 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
+∞
176.3
140
*
P39.1
ICD-10 Finland
Neonatal conjunctivitis and dacryocystitis
+∞
23.4
22
*
P39.4
ICD-10 Finland
Neonatal skin infection
+∞
11.6
11
*
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
+∞
11.6
11
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
14.5
9.9
16
12
P39.0
ICD-10 Finland
Neonatal infective mastitis
+∞
9.5
9
*
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.1
7.3
17
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
0
84
0.00
3.19
0.0
2.1
—
31.0
—
0
63
45
300
1.64
2.11
3.5
3.4
0.0
0.0
estimate
0.00
22
108
36
525
0.62
1.85
4.0
4.3
—
—
—
0
0
6
17
3.60
1.85
1.0
1.1
—
—
—
0
0
5
13
3.91
1.72
1.0
1.0
—
—
—
0
0
17
90
1.97
1.70
2.5
2.7
4.9
5.1
pmol/l
0.71
17
81
0
44
0.00
1.53
0.0
5.8
—
93.0
—
0
44
56
425
1.43
1.44
3.3
3.0
—
—
—
0
0
155
1396
1.42
1.42
10.1
11.7
3.9
3.9
mmol/l
0.15
150
1341
14
244
0.54
1.41
1.0
1.0
—
—
—
0
0
174
1609
1.48
1.30
9.6
10.4
21.3
22.4
mg/l
0.16
116
1046
62
765
0.73
1.27
1.6
1.8
0.3
2.3
u/ml
3.70
11
142
154
1400
1.38
1.22
10.1
11.7
139.5
139.5
mmol/l
0.01
149
1354
22
143
1.60
1.17
2.2
2.3
7.0
5.7
u/l
0.45
16
100
5
108
0.45
1.04
7.8
8.7
173.2
167.3
%
—
5
108
9
47
1.95
1.03
2.7
6.5
202.8
454.3
mg/l
—
9
47
21
304
0.66
1.03
2.2
3.6
—
—
—
0
0
124
1365
0.77
1.02
4.5
3.7
2.1
2.0
mu/l
0.41
111
1282
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
7
130
0.52
0.91
6.7
8.8
96.1
94.3
%
—
7
130
18
120
1.55
0.88
1.8
1.4
508.5
63809944.8
pmol/l
0.50
11
105
164
1538
1.30
0.82
12.6
14.6
13.2
13.0
%
1.29
157
1505
6
33
1.84
0.79
1.2
2.4
—
—
—
0
0
0
25
0.00
0.79
0.0
6.0
—
—
—
0
0
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
51
422
1.27
0.74
4.2
4.5
0.1
0.2
e6/l
1.05
34
323
57
481
1.25
0.71
4.8
4.8
—
—
—
0
0
169
1763
0.78
0.67
4.0
3.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
115.5
—
0
20
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.7
—
6.8
—
0
10
68
766
0.83
0.58
2.3
4.5
22.8
25.2
u/l
0.39
59
740
23
177
1.34
0.57
1.2
1.2
8.8
14.0
iu/ml
—
5
37
70
620
1.19
0.54
3.6
3.3
0.0
0.0
estimate
0.00
20
106
70
621
1.19
0.53
5.1
4.7
0.0
0.0
estimate
0.00
22
114
83
913
0.85
0.53
2.9
2.8
4.3
4.3
mmol/l
0.23
78
867
6
40
1.51
0.52
1.7
1.6
—
—
—
0
0
81
891
0.85
0.51
2.7
2.7
1.4
1.4
mmol/l
0.40
75
840
70
626
1.18
0.48
3.7
3.3
0.0
0.0
estimate
0.00
22
109
35
293
1.23
0.48
5.2
8.2
1.1
1.2
mmol/l
0.14
22
208
7
48
1.47
0.47
1.1
1.4
—
—
—
0
0
7
48
1.47
0.47
1.1
1.4
—
—
—
0
0
156
1490
1.18
0.45
7.4
8.6
23.4
24.7
u/l
0.48
146
1425
6
94
0.63
0.43
2.3
2.2
—
89.3
—
0
6
8
58
1.39
0.42
5.8
11.8
22.3
23.3
mmol/l
—
8
52
36
307
1.21
0.42
1.6
1.4
101.6
100.0
pmol/l
0.07
19
161
78
849
0.87
0.41
2.7
2.6
1.3
1.1
mmol/l
1.08
73
809
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.48
0.40
1.0
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
86.4
—
0
18
115
1217
0.88
0.40
4.3
3.3
14.4
14.3
pmol/l
0.10
102
1086
9
67
1.36
0.38
2.6
2.3
—
—
—
0
0
22
180
1.25
0.37
1.8
2.1
—
—
—
0
0
15
189
0.78
0.36
1.5
1.2
—
—
—
0
0
6
47
1.28
0.32
1.7
2.4
—
—
—
0
0
99
930
1.12
0.32
7.8
6.3
114.2
115.0
ml/min/173m2
0.12
64
583
74
796
0.89
0.31
4.5
3.5
75.6
51.4
ug/l
0.36
69
747
48
530
0.88
0.31
3.1
2.6
—
—
—
0
0
108
1023
1.11
0.30
4.7
4.6
8.7
6.7
mm/h
0.68
102
948
8
108
0.73
0.29
1.6
1.5
—
—
—
0
0
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
89
944
0.90
0.29
2.1
2.2
5.6
5.3
mmol/l
0.43
75
848
46
507
0.88
0.29
3.0
2.4
—
—
—
0
0
172
1674
1.15
0.29
11.5
13.1
39.7
39.9
%
0.13
143
1480
30
262
1.17
0.28
3.6
4.3
3.6
3.2
e6/l
0.07
15
156
17
140
1.23
0.28
1.9
2.1
—
—
—
0
0
74
791
0.90
0.28
3.5
2.9
36.8
36.6
mmol/mol
0.05
69
744
29
256
1.15
0.24
3.6
4.2
0.5
0.8
e6/l
0.24
13
149
5
37
1.36
0.23
1.0
5.8
—
—
—
0
0
5
37
1.36
0.23
1.2
2.3
—
—
—
0
0
85
894
0.92
0.22
2.5
2.1
—
—
—
0
0
71
667
1.10
0.22
9.6
11.3
1.2
1.2
mmol/l
0.05
62
605
0
10
0.00
0.21
0.0
4.4
—
254.9
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
27.0
—
0
10
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
17
145
1.19
0.21
1.8
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
84.0
—
0
6
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
63.2
—
0
6
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
10
80
1.26
0.20
4.8
3.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
49
1.23
0.20
1.7
2.4
—
—
—
0
0
15
128
1.18
0.18
1.7
1.4
—
—
—
0
0
7
59
1.19
0.18
1.4
1.4
—
—
—
0
0
10
120
0.82
0.17
1.0
1.9
—
—
—
0
0
5
66
0.75
0.17
1.8
1.6
—
—
—
0
0
86
895
0.93
0.16
2.7
2.7
2.6
2.6
mmol/l
0.19
80
839
6
76
0.78
0.16
1.0
1.1
—
8.8
—
0
13
35
323
1.10
0.15
12.4
13.0
25.0
25.1
mmol/l
0.04
35
323
19
169
1.14
0.15
1.2
1.1
1.0
9.6
u/ml
—
5
56
51
481
1.08
0.14
4.8
8.0
12.5
12.5
umol/l
0.00
45
444
5
47
1.06
0.09
1.4
4.6
28.2
28.2
%
—
5
47
34
321
1.07
0.09
9.9
11.3
0.7
1.4
mmol/l
0.57
28
258
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
5
61
0.81
0.08
1.2
1.3
—
—
—
0
0
13
117
1.12
0.08
1.9
2.0
—
—
—
0
0
12
133
0.90
0.08
1.8
1.9
—
—
—
0
0
13
143
0.90
0.08
1.7
1.3
—
—
—
0
0
33
346
0.94
0.07
2.9
2.3
—
—
—
0
0
34
324
1.06
0.07
10.0
11.2
6.0
5.9
kpa
0.07
34
310
88
863
1.03
0.05
6.2
5.4
116.3
117.5
u/l
0.05
82
806
31
299
1.04
0.04
2.5
2.1
—
—
—
0
0
104
1027
1.02
0.03
9.1
11.3
3.5
3.4
e9/l
0.20
87
868
42
411
1.03
0.02
2.7
3.8
2.6
2.7
mg/l
0.10
37
361
10
93
1.08
0.02
1.6
1.3
—
—
—
0
0
32
312
1.03
0.01
10.1
10.9
5.3
5.0
kpa
0.40
32
299
14
133
1.06
0.01
1.6
1.9
239.1
175.0
u/ml
—
8
59
14
134
1.05
0.00
1.6
1.9
—
—
—
0
0
24
234
1.03
0.00
2.9
5.4
0.5
1.4
mg/l
1.33
14
161
12
124
0.96
0.00
1.3
1.4
—
—
—
0
0
22
215
1.02
0.00
10.4
14.3
6.1
5.1
mmol/l
0.56
22
210
16
159
1.01
0.00
1.3
1.3
3.9
3.1
u/ml
0.08
11
99
17
168
1.01
0.00
2.8
3.2
2143.7
1350.3
ng/l
—
7
85
12
119
1.01
0.00
1.0
1.2
—
—
—
0
0
21
213
0.98
0.00
2.3
2.3
13.6
15.8
ng/l
—
7
69
11
110
1.00
0.00
1.1
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
1.8
—
0
5
0
5
0.00
0.00
0.0
1.2
—
25.4
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
67
0.89
0.00
1.3
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
5
59
0.84
0.00
6.2
11.8
—
96.7
—
0
7
0
5
0.00
0.00
0.0
1.2
—
1.4
—
0
5
0
5
0.00
0.00
0.0
7.4
—
3.7
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
6
64
0.93
0.00
1.7
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
6
61
0.98
0.00
5.2
12.7
—
425.5
—
0
13
6
60
1.00
0.00
11.7
14.1
0.9
1.2
%
—
6
60
5
57
0.87
0.00
1.2
1.4
—
—
—
0
0
6
60
1.00
0.00
11.7
14.1
0.6
0.7
%
—
6
60
6
68
0.88
0.00
2.2
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
13.7
—
—
—
0
0
8
79
1.01
0.00
1.6
1.9
—
—
—
0
0
5
49
1.02
0.00
1.4
4.4
—
—
—
0
0
5
58
0.86
0.00
13.6
14.5
24.0
24.1
mmol/l
—
5
58
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD – Other infections specific to the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data